These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23467560)

  • 1. Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure.
    Berg AH; Drechsler C; Wenger J; Buccafusca R; Hod T; Kalim S; Ramma W; Parikh SM; Steen H; Friedman DJ; Danziger J; Wanner C; Thadhani R; Karumanchi SA
    Sci Transl Med; 2013 Mar; 5(175):175ra29. PubMed ID: 23467560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis.
    Kalim S; Trottier CA; Wenger JB; Wibecan J; Ahmed R; Ankers E; Karumanchi SA; Thadhani R; Berg AH
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1809-1816. PubMed ID: 27445162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Carbamylation in Peritoneal Dialysis and the Effect of Low Glucose Plus Amino Acid Solutions.
    Trottier C; Perl J; Freeman M; Thadhani R; Berg A; Kalim S
    Perit Dial Int; 2018; 38(2):149-152. PubMed ID: 29563277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative CKD risk prediction using homocitrulline and carbamylated albumin: two circulating markers of protein carbamylation.
    Awwad A; Rhee EP; Grams M; Choles HR; Sondheimer J; He J; Chen J; Hsu CY; Vasan RS; Kimmel PL; Wulczyn K; Berg A; Lash J; Tang M; Kalim S;
    BMC Nephrol; 2024 May; 25(1):185. PubMed ID: 38816682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.
    Drechsler C; Kalim S; Wenger JB; Suntharalingam P; Hod T; Thadhani RI; Karumanchi SA; Wanner C; Berg AH
    Kidney Int; 2015 Jun; 87(6):1201-8. PubMed ID: 25671766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Carbamylation and the Risk of ESKD in Patients with CKD.
    Kalim S; Zhao S; Tang M; Rhee EP; Allegretti AS; Nigwekar S; Karumanchi SA; Lash JP; Berg AH
    J Am Soc Nephrol; 2023 May; 34(5):876-885. PubMed ID: 36757153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein carbamylation in kidney disease: pathogenesis and clinical implications.
    Kalim S; Karumanchi SA; Thadhani RI; Berg AH
    Am J Kidney Dis; 2014 Nov; 64(5):793-803. PubMed ID: 25037561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of carbamylated albumin by extended hemodialysis.
    Perl J; Kalim S; Wald R; Goldstein MB; Yan AT; Noori N; Kiaii M; Wenger J; Chan C; Thadhani RI; Karumanchi SA; Berg AH
    Hemodial Int; 2016 Oct; 20(4):510-521. PubMed ID: 27329430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Parenteral Amino Acid Therapy on Protein Carbamylation in Maintenance Hemodialysis Patients.
    Kalim S; Ortiz G; Trottier CA; Deferio JJ; Karumanchi SA; Thadhani RI; Berg AH
    J Ren Nutr; 2015 Jul; 25(4):388-92. PubMed ID: 25753604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease.
    Lenglet A; Rahali MA; Sauvage FL; Liabeuf S; Choukroun G; Essig M; El Balkhi S; Massy ZA
    Drugs R D; 2021 Jun; 21(2):231-238. PubMed ID: 34101139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease.
    Kalim S; Tamez H; Wenger J; Ankers E; Trottier CA; Deferio JJ; Berg AH; Karumanchi SA; Thadhani RI
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1927-34. PubMed ID: 23970130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urea and protein carbamylation in ESRD: surrogate markers or partners in crime?
    Velasquez MT; Ramezani A; Raj DS
    Kidney Int; 2015 Jun; 87(6):1092-4. PubMed ID: 26024026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study.
    Kalim S; Berg AH; Karumanchi SA; Thadhani R; Allegretti AS; Nigwekar S; Zhao S; Srivastava A; Raj D; Deo R; Frydrych A; Chen J; Sondheimer J; Shafi T; Weir M; Lash JP;
    Nephrol Dial Transplant; 2021 Dec; 37(1):139-147. PubMed ID: 33661286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein carbamylation in end stage renal disease: is there a mortality effect?
    Kalim S
    Curr Opin Nephrol Hypertens; 2018 Nov; 27(6):454-462. PubMed ID: 30148723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased carbamylation level of HDL in end-stage renal disease: carbamylated-HDL attenuated endothelial cell function.
    Sun JT; Yang K; Lu L; Zhu ZB; Zhu JZ; Ni JW; Han H; Chen N; Zhang RY
    Am J Physiol Renal Physiol; 2016 Mar; 310(6):F511-7. PubMed ID: 26764205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of how carbamylation reduces albumin binding to FcRn contributing to increased vascular clearance.
    Yadav SPS; Sandoval RM; Zhao J; Huang Y; Wang E; Kumar S; Campos-Bilderback SB; Rhodes G; Mechref Y; Molitoris BA; Wagner MC
    Am J Physiol Renal Physiol; 2021 Jan; 320(1):F114-F129. PubMed ID: 33283642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein carbamylation predicts mortality in ESRD.
    Koeth RA; Kalantar-Zadeh K; Wang Z; Fu X; Tang WH; Hazen SL
    J Am Soc Nephrol; 2013 Apr; 24(5):853-61. PubMed ID: 23431074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors determining hemoglobin carbamylation in renal failure.
    Stim J; Shaykh M; Anwar F; Ansari A; Arruda JA; Dunea G
    Kidney Int; 1995 Nov; 48(5):1605-10. PubMed ID: 8544421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum albumin and mortality in patients with HIV and end-stage renal failure on peritoneal dialysis.
    Ndlovu KCZ; Chikobvu P; Mofokeng T; Gounden V; Assounga A
    PLoS One; 2019; 14(6):e0218156. PubMed ID: 31181128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Pre-End-Stage Renal Disease Serum Albumin With Post-End-Stage Renal Disease Outcomes Among Patients Transitioning to Dialysis.
    Hsiung JT; Kleine CE; Naderi N; Park C; Soohoo M; Moradi H; Rhee CM; Obi Y; Kopple JD; Kovesdy CP; Kalantar-Zadeh K; Streja E
    J Ren Nutr; 2019 Jul; 29(4):310-321. PubMed ID: 30642656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.